20 June 2013
Keywords: fda, accepts, filing, nda, fixed-dose, loratadine/montelukast, combo
Article | 03 September 2007
Schering-Plough and Merck Pharmaceuticals, a unit of fellow US drug major Merck & Co, say that the New Drug Application filing ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
3 September 2007
19 June 2013
© 2013 thepharmaletter.com